Antibody Discovery Market 2030 by Source (Humanized Antibody, Human Antibody, Chimeric Antibody and Murine Antibody), Antibody Type (Polyclonal Antibodies and Recombinant Antibodies), Method, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Industry : Healthcare | Pages : 189 Pages | Published On : Mar 2024

         
     

The Antibody Discovery Market was valued USD 6.9 Billion in 2023 and projected to reach USD 13.7 Billion by 2030, growing at a CAGR of 9.0% during the forecast period of 2023-2030.

Antibody Discovery Market Size


Graph
             2019                         2023-2030      

ReportDetails
Market Size ValueUSD 6.9 Billion in 2023
Market Size ValueUSD 13.7 Billion by 2030
CAGR9.0%
Forecast Period2023-2030
Historic Data2019
Forecast UnitsValue (USD Million/USD Billion)
Segments CoveredSource, Antibody Type, Method, End User and Region
Geographics CoveredNorth America, Europe, Asia Pacific, and RoW

Major vendors in the global Antibody Discovery market:  Biocytogen, Charles River Laboratories, Creative Biolabs, Danaher Corporation, Eurofins Scientific, Evotec, Fairjourney Biologics S.A, Genscript Technology Corporation, Sartorius AG, Twist Bioscience and Others.

Market Overview

In recent years, the antibody discovery market has witnessed significant expansion, propelled by a growing need for precision therapeutics and the escalating incidence of chronic and infectious diseases. The process of antibody discovery entails the recognition and creation of antibodies designed to selectively bind to disease targets, presenting promising uses in diagnostics, therapeutics, and research. This market incorporates diverse technologies and platforms, including hybridoma technology, phage display, and transgenic animal models, facilitating the creation and enhancement of antibodies tailored for particular disease indications.

Increasing Demand for Targeted Therapeutics

The antibody discovery market is witnessing a surge in demand for targeted therapeutics, marking a notable trend in recent times. This heightened demand is driven by the recognition of the unique advantages offered by targeted therapeutic approaches. As precision medicine gains prominence, there is an increasing emphasis on developing antibodies that can specifically bind to disease targets. This targeted therapeutic strategy not only enhances treatment efficacy but also minimizes adverse effects on healthy tissues, showcasing a promising paradigm shift in the field of antibody discovery. The market is dynamically responding to this shift, with researchers and pharmaceutical entities actively pursuing innovative solutions to cater to the rising need for precision in therapeutic interventions.

Market Dynamics

Drivers:

  • Rising Prevalence of Chronic and Infectious Diseases
  • Increasing Research and Development Investment
  • Advancements in antibody engineering

Opportunities:

  • Development of new antibody-based therapies
  • Development of novel antibody discovery platforms
  • Expansion into new therapeutic areas

Increased adoption of personalized medicine

The Antibody Discovery Market is witnessing an increased adoption of personalized medicine, reflecting a paradigm shift in healthcare strategies. The recognition of individual variations in genetic makeup, responses to treatments, and disease manifestations has fueled the integration of personalized medicine into antibody discovery. This approach tailors medical interventions to the unique characteristics of each patient, maximizing treatment efficacy and minimizing adverse effects. The Antibody Discovery Market's alignment with personalized medicine signifies a progressive move towards more precise and patient-centric therapeutic solutions, harnessing the potential of antibodies to cater to the specific needs and genetic profiles of individuals.

The market for Antibody Discovery is dominated by North America.

In 2022, the North American antibody discovery market is anticipated to dominate in the forecast period, propelled by an increase in cancer prevalence, a robust presence of the antibody discovery industry, and technological advancements in the R&D sector. For instance, in 2020, the American Cancer Society reported approximately 1.8 million new cancer cases and 606,520 cancer-related deaths in the U.S., underscoring the demand for therapeutic antibodies and stimulating market growth. The upsurge in funding facilitates the development of novel technologies, collaborative efforts spanning countries and organizations, and the exploration of existing antibody treatments, contributing to a deeper understanding of the immune system and the effective development of targeted antibodies. Moreover, augmented funding enables large-scale clinical trials essential for evaluating antibody efficacy, thereby enhancing the overall growth trajectory of the market.

On the other hand, the Asia-Pacific antibody discovery market is poised for expansion in the forecast period due to an increase in the incidence of cardiovascular diseases and other chronic health conditions. As reported by the Journal of Biomedical and Environmental Science in 2021, approximately 330 million individuals in China experienced cardiovascular diseases. The significance of antibody discovery becomes evident in the creation of innovative therapeutics for addressing cardiovascular ailments. Consequently, the rising prevalence of heart diseases amplifies the demand for antibody discovery, playing a pivotal role in propelling market growth.

The Phage Display Antibody Discovery Segment is Anticipated to Hold the Largest Market Share During the Forecast Period

Based on technology the antibody discovery market is segmented into Phage Display, Hybridoma, Transgenic Antibody Technology, Single B Cell Technology and Others. The dominance of the phage display segment in the antibody discovery market is anticipated to persist. Phage display facilitates the generation of diverse antibody libraries, encompassing fully human, humanized, or synthetic libraries, thereby increasing the likelihood of identifying antibodies with optimal therapeutic characteristics. This method finds widespread application in target discovery, enabling researchers to pinpoint antibodies effective against a broad spectrum of targets, including proteins, peptides, and small molecules. Its versatility renders it a favored option in drug discovery. Through phage display, researchers can screen for functional antibodies that not only bind to the target but also demonstrate specific biological activities, such as receptor blocking or pathogen neutralization. The technique allows the selection of high-affinity antibodies through successive rounds of panning and amplification, ensuring the isolation of antibodies with robust and specific binding to the target.

Major Segmentations Are Distributed as follows:

  • By Source
    • Humanized Antibody
    • Human Antibody
    • Chimeric Antibody
    • Murine Antibody
  • By Type
    • Monoclonal Antibodies (mAbs)
    • Polyclonal Antibodies
    • Recombinant Antibodies
  • By Technology
    • Phage Display
    • Hybridoma
    • Transgenic Antibody Technology
    • Single B Cell Technology
    • Others
  • End-user
    • Pharmaceutical & Biotechnology industry
    • Research laboratory
    • Academic laboratory
  • By Region
    • North America
      • US
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
      • Chile
      • Peru
      • Rest of Latin America
    • Europe
      • Germany
      • France
      • Italy
      • Spain
      • U.K.
      • BENELUX
      • CIS & Russia
      • Nordics
      • Austria
      • Poland
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Thailand
      • Indonesia
      • Malaysia
      • Vietnam
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Nigeria
      • Egypt
      • Israel
      • Turkey
      • Rest of MEA

Recent Developments

  • In November 2022, Beigene announced FDA approval of Opzelura (brexafolumab) for the treatment of adults with mantle cell lymphoma (MCL) who have relapsed after one or more lines of therapy
  • In October 2023, AbbVie initiated Phase 1 clinical trial of Rovalpituzumab tesirine (Rova-T), an antibody-drug conjugate (ADC) targeting Nectin-4 for the treatment of solid tumors

Answers to Following Key Questions:

  • What will be the Antibody Discovery Market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers of Antibody Discovery Market?
  • What are the main forces behind worldwide Antibody Discovery Market? Which companies dominate Antibody Discovery Market?
  • Which companies dominate Antibody Discovery Market? Which business possibilities, dangers, and tactics did they embrace in the market?
  • What are the global Antibody Discovery industry's suppliers' opportunities and dangers in Antibody Discovery Market?
  • What is the Antibody Discovery industry's regional sales, income, and pricing analysis? In the Antibody Discovery Market, who are the distributors, traders, and resellers?
  • What are the main geographic areas for various trades that are anticipated to have astounding expansion over the Antibody Discovery Market?
  • What are the main geographical areas for various industries that are anticipated to observe astounding expansion for Antibody Discovery Market?
  • What are the dominant revenue-generating regions for Antibody Discovery Market, as well as regional growth trends?
  • By the end of the forecast period, what will the market size and growth rate be?
  • What are the main Antibody Discovery Market trends that are influencing the market's expansion?
  • Which key product categories dominate Antibody Discovery Market? What is Antibody Discovery Market’s main applications?
  • In the coming years, which Antibody Discovery Market technology will dominate the market?

Reason to purchase this Antibody Discovery Market Report:

  • Determine prospective investment areas based on a detailed trend analysis of the global Antibody Discovery Market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different Antibody Discovery Market segments in the top spending countries across the world and identify the opportunities each offers.
  • Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels that are driving the global Antibody Discovery Market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global Antibody Discovery Market.
  • Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top Antibody Discovery Market providers worldwide, including information about their products, alliances, recent contract wins, and financial analysis wherever available.

TOC

Table and Figures

Methodology:

At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

Antibody Discovery Market
Customize your Report
• Tailored advice to Drive your Performance
• Product Planning Strategy
• New Product Stratergy
• Expanded Research Scope
• Comprehensive Research
• Strategic Consulting
• Provocative and pragmatic
• Accelerate Revenue & Growth
• Evaluate the competitive landscape
• Optimize your partner network
• Analyzing industries
• Mapping trends
• Strategizing growth
• Implementing plans
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)

Email: sales@marketdigits.com